Upgrade to SI Premium - Free Trial

Sarepta Therapeutics (SRPT) Tops Q2 EPS by 54c

August 7, 2019 5:38 PM
Sarepta Therapeutics (NASDAQ: SRPT) reported Q2 EPS of ($0.83), $0.54 better than the analyst estimate of ($1.37). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings

Next Articles